Ongoing Trials

Please select a clinical trial from below to learn more.

1. Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated

Click Here to Learn More...

2. Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Click Here to Learn More...

3. TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma

Click Here to Learn More...

4. TRC105 for Liver Cancer That Has Not Responded to Sorafenib

Click Here to Learn More...

5. Sorafenib and TRC105 in Hepatocellular Cancer

Click Here to Learn More...

6. A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC)

Click Here to Learn More...

7. Open Label Dose-Finding Study of TRC105 Plus Capecitabine for Metastatic Breast Cancer

Click Here to Learn More...